This meta-analysis combines the results of two identical stroke studies (CARS-1 and CARS-2) assessing efficacy of Cerebrolysin on motor recovery during early rehabilitation. Cerebrolysin is a parenterally administered neuropeptide preparation approved for the treatment of stroke. Both studies had a prospective, randomized, double-blind, placebo-controlled design. Treatment with 30 ml Cerebrolysin once daily for 3 weeks was started 24–72 h after stroke onset. In addition, patients participated in a standardized rehabilitation program for 21 days that was initiated within 72 h after stroke onset. For both studies, the original analysis data were used for meta-analysis (individual patient data analysis). The combination of these two studies by meta-analytic procedures was pre-planned, and the methods were pre-defined under blinded conditions. The nonparametric Mann-Whitney (MW) effect size of the two studies on the ARAT score on day 90 indicated superiority of Cerebrolysin compared with placebo (MW 0.62, P < 0.0001, Wei-Lachin pooling procedure, day 90, last observation carried forward; N = 442). Also, analysis of early benefit at day 14 and day 21 by means of the National Institutes of Health Stroke Scale, which is regarded as most sensitive to early improvements, showed statistical significance (MW 0.59, P < 0.002). The corresponding number-needed-to-treat (NNT) for clinically relevant changes in early NIHSS was 7.1 (95% CI: 4 to 22). Cerebrolysin had a beneficial effect on motor function and neurological status in early rehabilitation patients after acute ischemic stroke. Safety aspects were comparable to placebo, showing a favourable benefit/risk ratio.
Wilcoxon F (1945) Individual comparisons by ranking methods. Biom Bull 1:80–83 CrossRef
Mann HB, Whitney DR (1947) On a test of whether one of two random variables is stochastically larger than the other. Ann Math Statistic 18:50–60 CrossRef
Armitage P, Bery G, Matthews JNS (2002) Statistical Methods in Medical Research, 4th edn. Blackwell Science, Malden CrossRef
Sprent P, Smeeton NC (2001) Applied Nonparametric Statistical Methods, 3rd edn. Chapman and Hall, Boca Raton
Rothmann MD, Wiens BL, Chan IS (2011) Design and Analysis of Non-Inferiority Trials. Chapman & Hall/CRC, Boca Raton
Cohen J (1988) Statistical power analysis for the behavioral sciences. Lawrence Erlbaum Associates, Hillsdale
Colditz GA, Miller JN, Mosteller F (1988) Measuring gain in the evaluation of medical technology: the probability of a better outcome. Int J Technol Assessment Health Care 4:637–642
Lachin JM (2000) Biostatistical methods. The assessment of relative risks. Wiley, New York
Frick H (1994) A maximin linear test and its application to Lachin’s Data. Commun Statist - Theory and Methods 23:1021–1029 CrossRef
Frick H (1995) Comparing trials with multiple outcomes: The multivariate one-sided hypothesis with unknown covariances. Biom J 8:909–917 CrossRef
Hedges LV, Olkin J (1985) Statistical Methods for Meta-Analysis. Academic Press, Inc., San Diego
Borenstein M, Hedges L, Rothstein H (2007) Introduction to Meta-Analysis. Wiley, New York
Borenstein M, Hedges L, Higgins J, Rothstein H (2009) Introduction to Meta-Analysis. Wiley, New York CrossRef
Deeks JJ, Higgins JP, Altman DG. Analysing Data and Undertaking Meta-analysis. In: Higgins JP, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. The Cochrane Collaboration; 2011.
Biester K, Lange S, Kaiser T, Potthast R (2006) High dropout rates in trials included in Cochrane Reviews. Paper presented at: XIV Cochrane Colloquium; Dublin, Ireland
Higgins JP, Altman DG, Sterne JA. Assessing risk of bias in included studies. In: Higgins JP, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. The Cochrane Collaboration; 2011.
Group NS (1995) Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA stroke study group. N Engl J Med 333(24):1581–1587 CrossRef
Morris JH, van Wijck (2010) Upper limb activity limitation after stroke: identifying severity subgroups using the Action Resarch Arm Test and the Nine Hole Peg Test. Int J Stroke 5(Suppl. 3):56
- Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials
Volker W. Rahlfs
Bogdan O. Popescu
- Springer Milan